Genomics and transcriptomics in drug discovery

Drug Discovery Today

Volumn 19, Issue 2, 2014, Pages 126-132

  Dopazo, Joaquin ^a,b  

^a CENTRO DE INVESTIGACIÓN PRÍNCIPE FELIPE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; PROTEIN; TRANSCRIPTOME;

ADVERSE DRUG REACTION; DATA ANALYSIS; DRUG DEVELOPMENT; DRUG INDUSTRY; DRUG REPOSITIONING; GENE SEQUENCE; GENE TARGETING; GENETIC HETEROGENEITY; GENOMICS; HUMAN; HUMAN GENOME; METAGENOMICS; REVIEW; TECHNOLOGY; TRANSCRIPTOMICS; HIGH THROUGHPUT SEQUENCING; MEDICAL RESEARCH; METABOLISM; MOLECULARLY TARGETED THERAPY; PROCEDURES; SYSTEMS BIOLOGY;

BIOLOGICAL MARKERS; BIOMEDICAL RESEARCH; DRUG DISCOVERY; DRUG INDUSTRY; GENOMICS; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; MOLECULAR TARGETED THERAPY; PROTEINS; SYSTEMS BIOLOGY; TRANSCRIPTOME;

EID: 84895929295     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2013.06.003     Document Type: Review

References (62)

1. C. Sotiriou, and M.J. Piccart Taking gene-expression profiling to the clinic: when will molecular signatures become relevant to patient care? Nat. Rev. Cancer 7 2007 545 553
2. L.J. van't Veer, and R. Bernards Enabling personalized cancer medicine through analysis of gene-expression patterns Nature 452 2008 564 570
3. S.J. Coons The FDA's Critical Path Initiative: a brief introduction Clin. Ther. 31 2009 2572 2573
4. L. Shi et al. The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models Nat. Biotechnol. 28 2010 827 838
5. L.A. Hindorff et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits Proc. Natl. Acad. Sci. U.S.A. 106 2009 9362 9367
6. T.A. Manolio et al. Finding the missing heritability of complex diseases Nature 461 2009 747 753
7. M.J. Bamshad et al. Exome sequencing as a tool for Mendelian disease gene discovery Nat. Rev. Genet. 12 2011 745 755
8. M.R. Stratton Exploring the genomes of cancer cells: progress and promise Science 331 2011 1553 1558
9. D. Falconer, and T. Mackay Introduction to Quantitative Genetics 1996 Longman
10. L.H. Hartwell et al. From molecular to modular cell biology Nature 402 1999 C47 C52
11. M.L. Metzker Sequencing technologies - the next generation Nat. Rev. Genet. 11 2010 31 46
12. M.G. Ross et al. Characterizing and measuring bias in sequence data Genome Biol. 14 2013 R51
13. N.J. Loman et al. Performance comparison of benchtop high-throughput sequencing platforms Nat. Biotechnol. 30 2012 434 439
14. The-1000-Genomes-Project-Consortium A map of human genome variation from population-scale sequencing Nature 467 2010 1061 1073
15. D.G. MacArthur, and C. Tyler-Smith Loss-of-function variants in the genomes of healthy humans Hum. Mol. Genet. 19 2010 R125 R130
16. Y. Xue et al. Deleterious- and disease-allele prevalence in healthy individuals: insights from current predictions, mutation databases, and population-scale resequencing Am. J. Hum. Genet. 91 2012 1022 1032
17. J. Carbonell et al. A map of human microRNA variation uncovers unexpectedly high levels of variability Genome Med. 4 2012 62
18. L.D. Stein The case for cloud computing in genome informatics Genome Biol. 11 2010 207
19. A. McKenna et al. The Genome Analysis Toolkit: a MapReduce framework for analysing next-generation DNA sequencing data Genome Res. 20 2010 1297 1303
20. B. Langmead et al. Cloud-scale RNA-sequencing differential expression analysis with Myrna Genome Biol. 11 2010 R83
21. I. Medina et al. VARIANT: Command Line, Web service and Web interface for fast and accurate functional characterization of variants found by Next-Generation Sequencing Nucleic Acids Res. 40 2012 W54 W58
22. B. Giardine et al. Galaxy: a platform for interactive large-scale genome analysis Genome Res. 15 2005 1451 1455
23. M. Garber et al. Computational methods for transcriptome annotation and quantification using RNA-seq Nat. Methods 8 2011 469 477
24. N.A. Fonseca et al. Tools for mapping high-throughput sequencing data Bioinformatics 28 2012 3169 3177
25. S. Tarazona et al. Differential expression in RNA-seq: a matter of depth Genome Res. 21 2011 2213 2223
26. E.E. Schadt et al. Computational solutions to large-scale data management and analysis Nat. Rev. Genet. 11 2010 647 657
27. I. Kola, and J. Landis Can the pharmaceutical industry reduce attrition rates? Nat. Rev. Drug Discov. 3 2004 711 715
28. I. Comino-Mendez et al. Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma Nat. Genet. 43 2011 663 667
29. R.D. Hawkins et al. Next-generation genomics: an integrative approach Nat. Rev. Genet. 11 2010 476 486
30. C. Auffray et al. Systems medicine: the future of medical genomics and healthcare Genome Med. 1 2009 2
31. A.L. Barabasi et al. Network medicine: a network-based approach to human disease Nat. Rev. Genet. 12 2011 56 68
32. Y. Moreau, and L.C. Tranchevent Computational tools for prioritizing candidate genes: boosting disease gene discovery Nat. Rev. Genet. 13 2012 523 536
33. L.G. Biesecker Exome sequencing makes medical genomics a reality Nat. Genet. 42 2010 13 14
34. S.R. Ahmad Adverse drug event monitoring at the Food and Drug Administration J. Gen. Intern. Med. 18 2003 57 60
35. M. Schwab, and E. Schaeffeler Pharmacogenomics: a key component of personalized therapy Genome Med. 4 2012 93
36. W.G. Feero et al. Genomic medicine - an updated primer N. Engl. J. Med. 362 2010 2001 2011
37. U.A. Meyer et al. Omics and drug response Annu. Rev. Pharmacol. Toxicol. 53 2013 475 502
38. M. Gerlinger et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing N. Engl. J. Med. 366 2012 883 892
39. D. Bell et al. Integrated genomic analyses of ovarian carcinoma Nature 474 2011 609 615
40. M. Wu et al. Interaction between Ras(V12) and scribbled clones induces tumour growth and invasion Nature 463 2010 545 548
41. P. Creixell et al. Navigating cancer network attractors for tumor-specific therapy Nat. Biotechnol. 30 2012 842 848
42. T. Le et al. Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use PLoS ONE 4 2009 E6079
43. T.A. Davies et al. Infrequent occurrence of single mutations in topoisomerase IV and DNA gyrase genes among US levofloxacin-susceptible clinical isolates of Streptococcus pneumoniae from nine institutions (1999-2003) J. Antimicrob. Chemother. 57 2006 437 442
44. J.T. Dudley et al. Exploiting drug-disease relationships for computational drug repositioning Brief Bioinform. 12 2011 303 311
45. S. Ekins et al. In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling Br. J. Pharmacol. 152 2007 9 20
46. T. Noeske et al. Predicting compound selectivity by self-organizing maps: cross-activities of metabotropic glutamate receptor antagonists ChemMedChem 1 2006 1066 1068
47. J. Lamb et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease Science 313 2006 1929 1935
48. F. Iorio et al. Discovery of drug mode of action and drug repositioning from transcriptional responses Proc. Natl. Acad. Sci. U.S.A. 107 2010 14621 14626
49. S. Suthram et al. Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets PLoS Comput. Biol. 6 2010 E1000662
50. X. Yang et al. Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks Nat. Genet. 41 2009 415 423
51. M. Campillos et al. Drug target identification using side-effect similarity Science 321 2008 263 266
52. J.C. Wooley et al. A primer on metagenomics PLoS Comput. Biol. 6 2010 E1000667
53. T. Sousa et al. The gastrointestinal microbiota as a site for the biotransformation of drugs Int. J. Pharm. 363 2008 1 25
54. H.J. Haiser, and P.J. Turnbaugh Is it time for a metagenomic basis of therapeutics? Science 336 2012 1253 1255
55. M.D. Collins, and G.R. Gibson Probiotics, prebiotics, and synbiotics: approaches for modulating the microbial ecology of the gut Am. J. Clin. Nutr. 69 1999 1052S 1057S
56. A. Khoruts et al. Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea J. Clin. Gastroenterol. 44 2010 354 360
57. E. Borenstein Computational systems biology and in silico modeling of the human microbiome Brief Bioinform. 13 2012 769 780
58. S. Freilich et al. Metabolic-network-driven analysis of bacterial ecological strategies Genome Biol. 10 2009 R61
59. H.W. Virgin, and J.A. Todd Metagenomics and personalized medicine Cell 147 2011 44 56
60. P.M. Woollard et al. The application of next-generation sequencing technologies to drug discovery and development Drug Discov. Today 16 2011 512 519
61. A.L. Barabasi, and Z.N. Oltvai Network biology: understanding the cell's functional organization Nat. Rev. Genet. 5 2004 101 113
62. I. Dunham et al. An integrated encyclopedia of DNA elements in the human genome Nature 489 2012 57 74